Literature DB >> 4361727

Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys.

P L Ogra, S S Ogra, S al-Nakeeb, P R Coppola.   

Abstract

By employing the techniques of immunofluorescence and radioimmunodiffusion using (32)P-labeled poliovirus as the antigen, the immunoglobulin response to poliovirus in serum, nasopharynx, spinal fluid, and in different segments of the central nervous system (CNS) was studied after intramuscular, oral, intranasal, and intrathalamic administration of inactivated (Salk), live attenuated (Sabin), or live virulent (Mahoney) type I poliovirus. Spinal fluid gammaG antibody was detected after immunization with Sabin or Mahoney virus and intramuscular administration of Salk vaccine. The response in the CNS was characterized by the appearance of gammaG antibody after oral or intrathalamic administration of Mahoney virus and rarely after intrathalamic inoculation of Sabin vaccine. The antibody activity in CNS was limited to the areas of poliovirus replication. Intrathalamic immunization with Mahoney virus resulted in local gammaG antibody production in the CNS in the absence of any detectable response in serum. Discrete foci of gammaG-containing cells were observed in those areas of CNS which contained poliovirus antibody. No immunoglobulin-containing cells or poliovirus antibody was seen in the CNS of monkeys immunized with intramuscularly or orally administered Sabin or Salk vaccine and in sham-immunized control monkeys. It is suggested that the CNS, when stimulated locally with a potent replicating viral antigen, may manifest a specific local antibody response, which is independent of the response in serum.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4361727      PMCID: PMC422953          DOI: 10.1128/iai.8.6.931-937.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  IS THE BRAIN "AN IMMUNOLOGICALLY PRIVILEGED SITE"?I. STUDIES BASED ON INTRACEREBRAL TUMOR HOMOTRANSPLANTATION AND ISOTRANSPLANTATION TO SENSITIZED HOSTS.

Authors:  L C SCHEINBERG; F L EDELMAN; W A LEVY
Journal:  Arch Neurol       Date:  1964-09

2.  Distribution of antibody to poliomyelitis in vaccinated and paralytic monkeys.

Authors:  I M MORGAN
Journal:  Fed Proc       Date:  1949-09

3.  Immunohistologic localization of immunoglobulins, secretory component, and lactoferrin in the developing human fetus.

Authors:  S S Ogra; P L Ogra; J Lippes; T B Tomasi
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

4.  Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

5.  Immunoglobulin content of intestinal mucosal plasma-cells in ataxia telangiectasia.

Authors:  S Eidelman; S D Davis
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

Review 6.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

8.  Is the brain an "immunologically privileged site"? 2. Studies in induced host resistance to transplantable mouse glioma following irradiation of prior implants.

Authors:  L C Scheinberg; A Levy; F Edelman
Journal:  Arch Neurol       Date:  1965-09

9.  Distribution of echovirus antibody in serum, nasopharynx, rectum, and spinal fluid after natural infection with echovirus type 6.

Authors:  P L Ogra
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

10.  The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues.

Authors:  D R Tourville; R H Adler; J Bienenstock; T B Tomasi
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  6 in total

1.  Prolonging morbidity in rabid dogs by intrathecal injection of attenuated rabies vaccine.

Authors:  G M Baer; J H Shaddock; L W Williams
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Antibody responses in the cerebrospinal fulid of cynomolgus monkeys after intracerebral inoculation with paramyxoviruses.

Authors:  K Yamanouchi; T A Sato; F Kobune; A Shishido
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Antibody response to rabies virus in Syrian hamsters.

Authors:  J E Coe; J F Bell
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

4.  Mumps or Coxsackie A9 virus antibody in the cerebrospinal fluid of patients with meningitis or encephalitis.

Authors:  J H Connolly; F L Robinson; D A Canavan
Journal:  Ir J Med Sci       Date:  1975-12       Impact factor: 1.568

Review 5.  Current progress in the development of a prophylactic vaccine for HIV-1.

Authors:  Lena J Gamble; Qiana L Matthews
Journal:  Drug Des Devel Ther       Date:  2010-12-22       Impact factor: 4.162

Review 6.  Neurotropic Enterovirus Infections in the Central Nervous System.

Authors:  Hsing-I Huang; Shin-Ru Shih
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.